Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Progressive Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03174938
What this trial is testing

The Swedish BioFINDER 2 Study

Who this might be right for
DementiaAlzheimer DiseaseParkinson Disease+10 more
Skane University Hospital 2,950
Testing effectiveness (Phase 2)UnknownNCT01144117
What this trial is testing

The Effects of Erythropoietin on Clinical Disability and Brain Pathology in Patients With Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (Primary or Secondary Progressive Phase).
Rigshospitalet, Denmark 56
Not applicableNot Yet RecruitingNCT07631923
What this trial is testing

Acute Intermittent Hypoxia Combined With Gait Training in Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+1 more
Shirley Ryan AbilityLab 35
Not applicableLooking for participantsNCT02795052
What this trial is testing

Neurologic Stem Cell Treatment Study

Who this might be right for
Neurologic DisordersNervous System DiseasesNeurodegenerative Diseases+23 more
MD Stem Cells 500
Not applicableNot Yet RecruitingNCT06171334
What this trial is testing

Remote Ischemic Conditioning in PPMS

Who this might be right for
Multiple Sclerosis
University of Calgary 45
Testing effectiveness (Phase 2)Ended earlyNCT03362294
What this trial is testing

Safety and Efficacy of Monthly Long-acting IM Injection of 25mg or 40 mg GA Depot in Subjects With PPMS

Who this might be right for
Primary Progressive Multiple Sclerosis
Mapi Pharma Ltd. 30
Not applicableStudy completedNCT01080014
What this trial is testing

Correlation Between Multiple Sclerosis Functional Composite (MSFC) and Expanded Disability Status Scale (EDSS) in Patients With Multiple Sclerosis (MS) in Argentina

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 252
Early research (Phase 1)WithdrawnNCT05029609
What this trial is testing

Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple SclerosisMultiple Sclerosis
Tiziana Life Sciences LTD
Not applicableStudy completedNCT01776060
What this trial is testing

Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study

Who this might be right for
Primary Progressive Multiple Sclerosis
Duke University 28
Early research (Phase 1)Study completedNCT02253264
What this trial is testing

Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis
Johns Hopkins University 8
Not applicableStudy completedNCT06436131
What this trial is testing

The Effects of In-phase Bilateral Exercise in People with Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
Cyprus University of Technology 20
Not applicableActive Not RecruitingNCT06209515
What this trial is testing

Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study

Who this might be right for
Neurodegenerative DiseasesAlzheimer DiseaseFrontotemporal Dementia+8 more
Kuopio University Hospital 61,292
Not applicableStudy completedNCT07264725
What this trial is testing

Libyan Multiple Sclerosis Registry Study

Who this might be right for
Multiple Sclerosis
University of Zintan 369
Early research (Phase 1)Looking for participantsNCT06680037
What this trial is testing

Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

Who this might be right for
B-cell Mediated Autoimmune Disorders
TG Therapeutics, Inc. 100
Post-approval studies (Phase 4)Looking for participantsNCT07609719
What this trial is testing

Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

Who this might be right for
Multiple Sclerosis
Genentech, Inc. 100
Not applicableStudy completedNCT01915433
What this trial is testing

Wahls Paleo Diet and Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Terry L. Wahls 15
Testing effectiveness (Phase 2)Study completedNCT01077466
What this trial is testing

Natalizumab Treatment of Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis
Rigshospitalet, Denmark 24
Not applicableStudy completedNCT04550650
What this trial is testing

Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients

Who this might be right for
Multiple Sclerosis, Chronic ProgressiveMultiple Sclerosis, Primary Progressive
Somogy Megyei Kaposi Mór Teaching Hospital 4
Not applicableStudy completedNCT05466682
What this trial is testing

RELAXaHEAD for Headache Patients (Phase II)

Who this might be right for
MigraineHeadacheMultiple Sclerosis+1 more
NYU Langone Health 48
Large-scale testing (Phase 3)Active Not RecruitingNCT04544449
What this trial is testing

Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Primary Progressive
Hoffmann-La Roche 985
Next Page